top of page

HEK293 TLR7 Reporter Cell Line

Item
Cat#
Price

Stable Cell Line

SNB-SP-0039

$1,980

Compound Test Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description




Product Specifications

Target Type

Signal Pathway

Species

Human

HGNC Symbol


Accession Number


Parental Line

HEK293

Lot#

See Vial

Storage

Liquid Nitrogen


Data

HEK293/TLR7 Luciferase Agonist Assay. HEK293/TLR7 NF-κB Luciferase reporter cells were treated with Flagellin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/TLR7 Luciferase Agonist Assay. HEK293/TLR7 NF-κB Luciferase reporter cells were treated with Flagellin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/TLR7 Luciferase Agonist Assay. HEK293/TLR7 NF-κB Luciferase reporter cells were treated with Flagellin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/TLR7 Luciferase Agonist Assay. HEK293/TLR7 NF-κB Luciferase reporter cells were treated with Flagellin. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.

Target Background




Product Documentation



Related Products


bottom of page